Document is current

Any future updates will be listed below

ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway

Crossref DOI link: https://doi.org/10.1186/s13046-017-0643-9

Published Online: 2017-11-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark